OLAVO PIRES DE CAMARGO

(Fonte: Lattes)
Índice h a partir de 2011
12
Lattes
ResearcherID
ORCID
Projetos de Pesquisa
Unidades Organizacionais
Departamento de Ortopediae Traumatologia, Faculdade de Medicina - Docente
LIM/41 - Laboratório de Investigação Médica do Sistema Músculoesquelético, Hospital das Clínicas, Faculdade de Medicina - Líder

Filtros

Limpar filtros

Configurações

Resultados de Busca

Agora exibindo 1 - 10 de 88
  • article 15 Citação(ões) na Scopus
    PUBLICATION RATES OF PAPERS PRESENTED AT THE BRAZILIAN ORTHOPEDIC MEETING
    (2013) EJNISMAN, Leandro; GOMES, Guilherme Seva; OLIVEIRA, Rafael Garcia de; MALAVOLTA, Eduardo Angeli; GOBBI, Riccardo Gomes; CAMARGO, Olavo Pires de
    Objective: To quantify the publication rates of the papers presented at the 2007 Brazilian Orthopedics Meeting (Congresso Brasileiro de Ortopedia - CBOT). Methods: Evaluation of the proportion of abstracts submitted by the various orthopedic subspecialties and according to the Brazilian states. Then, a Lilacs and PubMed search was performed in order to determine which presentations generated national or international published papers. Results: Sao Paulo and the Southeast region were responsible for the greatest number of presentations at the congress (54.1% and 68.3% respectively). Shoulder and Elbow were the subspecialty responsible for more presentations (13.8%). Among the 653 studies presented at the congress, 174 (26.6%) were published. Oral presentations obtained a publication rate 3.58 times higher than posters. Conclusion: The CBOT publication rate is lower than 30%. Many of the papers presented at the CBOT does not pass the scrutiny of scientific journals and therefore should not be the only source of scientific update of the participants: Descriptive Epidemiologic.
  • article 0 Citação(ões) na Scopus
    Untitled
    (2014) CAMARGO, Olavo Pires de
  • article 22 Citação(ões) na Scopus
    Validation of the Brazilian Version of the Musculoskeletal Tumor Society Rating Scale for Lower Extremity Bone Sarcoma
    (2013) REBOLLEDO, Daniel Cesar Seguel; VISSOCI, Joao Ricardo Nickenig; PIETROBON, Ricardo; CAMARGO, Olavo Pires de; BAPTISTA, Andre Mathias
    The Musculoskeletal Tumor Society (MSTS) rating scale is an English-language instrument used worldwide to assess functional evaluation of patients with musculoskeletal cancer. Despite its use in several studies in English-speaking countries, its validity for assessing patients in other languages is unknown. The translation and validation of widely used scales can facilitate the comparison across international patient samples. The objectives of this study were (1) to translate and culturally adapt the MSTS rating scale for functional evaluation in patients with lower extremity bone sarcomas to Brazilian Portuguese; (2) analyze its factor structure; and (3) test the reliability and (4) validity of this instrument. The MSTS rating scale for lower limbs was translated from English into Brazilian Portuguese. Translations were synthesized, translated back into English, and reviewed by a multidisciplinary committee for further implementation. The questionnaire was administered to 67 patients treated for malignant lower extremity bone tumors who were submitted to limb salvage surgery or amputation. They also completed a Brazilian version of the Toronto Extremity Salvage Score (TESS). Psychometric properties were analyzed including factor structure analysis, internal consistency, interobserver reliability, test-retest reliability, and construct validity (by comparing the adapted MSTS with TESS and discriminant validity). The MSTS rating scale for lower limbs was translated and culturally adapted to Brazilian Portuguese. The MSTS-BR proved to be adequate with only one latent dimension. The scale was also found to be reliable in a population that speaks Brazilian Portuguese showing good internal consistency (Cronbach's alpha = 0.84) and reliability (test-retest reliability and interobserver agreement of 0.92 and 0.98, respectively). Validity of the Brazilian MSTS rating scale was proved by moderate with TESS and good discriminant validity. The Brazilian version of the MSTS rating scale was translated and validated. It is a reliable tool to assess functional outcome in patients with lower extremity bone sarcomas. It can be used for functional evaluation of Brazilian patients and crosscultural comparisons.
  • article 4 Citação(ões) na Scopus
    SCHOOLING OF THE PATIENTS AND CLINICAL APLICATION OF QUESTIONNAIRES IN OSTEOARTHITIS
    (2014) CAMPOS, Gustavo Constantino de; KOHARA, Marcelo Tomio; REZENDE, Marcia Uchoa; SANTANA, Olga Fugiko Magashima; MOREIRA, Merilu Marins; CAMARGO, Olavo Pires de
    Objective: To evaluate the consistency of the questionnaires (WOMAC, Lequesne, VAS, SF 36-PCS and SF 36-MCS) when applied in patients with osteoarthritis of the knees (KOA) verifying if age and level of education interfere with the completion of the questionnaires. Method: One hundred and two patients with KOA answered WOMAC, LESQUESNE, VAS and SF-36 questionnaires and provided data correlated with age and education. The internal consistency of the WOMAC questionnaire was verified with Cronbach's alpha. Pearson's correlations between the questionnaires, age and educational level was performed. Results: Mean age was 65 years old. Schooling averaged 7.94 years; WOMAC 47.95; VAS 63.57; Lequesne 12.29; PCS and MCS 31.91 43.68. Cronbach's alpha for WOMAC 0.9. Education did not affect WOMAC response (r=-0.182, p = 0.067) and MCS (r=0.021 / p=0.835), but showed weak but significant correlation with VAS (r=-0.264 / p=0.007), Lequesne (r=0.277, p=0.005) and PCS (r=0.309/ p=0.002). Age showed significant direct correlation only with PCS (r=0.205, p=0.039). Conclusion: The level of education does not interfere with the completion of WOMAC but may interfere with completing VAS, Lequesne and physical component of SF-36.
  • article 25 Citação(ões) na Scopus
    Prophylactic antibiotic regimens in tumour surgery (PARITY) A PILOT MULTICENTRE RANDOMISED CONTROLLED TRIAL
    (2015) GHERT, M.; BHANDARI, M.; DEHESHI, B.; GUYATT, G.; HOLT, G.; O'SHEA, T.; RANDALL, R. L.; THABANE, L.; WUNDER, J.; EVANIEW, N.; MCKAY, P.; SCHNEIDER, P.; TURCOTTE, R.; MADDEN, K.; SCOTT, T.; SPRAGUE, S.; SIMUNOVIC, N.; SWINTON, M.; RACANO, A.; HEELS-ANSDELL, D.; BUCKINGHAM, L.; ROSE, P.; BRIGMAN, B.; PULLENAYEGUM, E.; GHERT, M.; EVANIEW, N.; MCKAY, P.; SCHNEIDER, P.; SOBHI, G.; CHAN, R.; BILJAN, M.; FERGUSON, P.; WUNDER, J.; GRIFFIN, A.; MANTAS, I.; WYLIE, A.; HAN, A.; GREWAL, G.; TURCOTTE, R.; GOULDING, K.; DANDACHLI, F.; MATTE, G.; WERIER, J.; ABDELBARY, H.; PAQUIN, K.; COSGROVE, H.; DUGAL, A-M.; FETZER, S.; AIKENS, W.; CLARKSON, P.; WANG, B.; KONDO, L.; YIP, J.; ISLER, M.; MOTTARD, S.; BARRY, J.; YVES, H. St; QUACH, M.; ASSAYAG, H.; DAOUST, K.; GOYETTE, K.; PROJEAN, D.; DION, N.; ARTEAU, A.; TURMEL, S.; BERTRAND, A.; GAGNON, N.; LABBE, V.; HOLT, G.; HALPERN, J.; SCHWARTZ, H.; ATKINSON, A.; DANIELS, J.; MOORE, M. S.; ANDERSON, M.; GEBHARDT, M.; WAGNER, K.; PATEL, H.; JOLIN, H.; ANDERSON, M.; GEBHARDT, M.; ALLAR, B.; NAQVI, M.; BENNETT, J.; ALBUQUERQUE, S.; RANDALL, R. L.; JONES, K.; CRABTREE, S.; DAVIS, R.; SORENSON, S.; HEALEY, J. H.; GALLE, J.; O'NEILL, G.; CORRAL, B. Del; LOPEZ, S.; SERRA, M. Galli; PARIZZIA, W.; PODRZAJ, A.; TORRES, M. Foa; CLAYER, M.; CHAI, Y.; SLOBODIAN, P.; BALACH, T.; COYLE, K.; LACASSE, R.; ABRAHAM, J.; MORRISON, T.; ANGELOS, M.; SAILOR, L.; SADAKA, R.; MILLER, B.; MILHEM, M.; MCCURDY, N.; KAIN, J.; NOHR, J.; JOHNSON, K.; MERRISS, A.; CHENG, E.; LUKE, D. G.; SCHARSCHMIDT, T. J.; CRIST, M. K.; DIMEO, A.; MARMON, L.; REIMER, N.; MONSON, D.; OSKOUEI, S.; LOMBA, C.; ROGERS, S.; AVEDIAN, R.; JORDAN, L.; CHINN, S.; HAMILTON, M.; GHERT, M.; EVANIEW, N.; MCKAY, P.; SCHNEIDER, P.; SOBHI, G.; CHAN, R.; BIL-JAN, M.; FERGUSON, P.; WUNDER, J.; GRIFFIN, A.; MANTAS, I.; WYLIE, A.; HAN, A.; GREWAL, G.; TURCOTTE, R.; GOULDING, K.; DANDACHLI, F.; MATTE, G.; WERIER, J.; ABDELBARY, H.; PAQUIN, K.; COSGROVE, H.; DUGAL, A-M.; FETZER, S.; AIKENS, W.; CLARKSON, P.; WANG, B.; KONDO, L.; YIP, J.; ISLER, M.; MOTTARD, S.; BARRY, J.; YVES, H. St.; QUACH, M.; ASSAYAG, H.; DAOUST, K.; GOYETTE, Kristine; PROJEAN, D.; DION, N.; ARTEAU, A.; TURMEL, S.; BERTRAND, A.; GAGNON, N.; LABBE, V.; HOLT, G.; HALPERN, J.; SCHWARTZ, H.; ATKINSON, A.; DANIELS, J.; MOORE, M. S.; ANDERSON, M.; GEBHARDT, M.; WAGNER, K.; PATEL, H.; JOLIN, H.; ANDERSON, M.; GEBHARDT, M.; ALLAR, B.; NAQVI, M.; BENNETT, J.; ALBUQUERQUE, S.; RANDALL, R. L.; JONES, K.; CRABTREE, S.; DAVIS, R.; SORENSON, S.; HEALEY, J. H.; GALLE, J.; O'NEILL, G.; CORRAL, B. Del; LOPEZ, S.; SERRA, M. Galli; PARIZZIA, W.; PODRZAJ, A.; TORRES, M. Foa; CLAYER, M.; TRAN, N.; SLOBODIAN, P.; BALACH, T.; COYLE, K.; LACASSE, R.; ABRAHAM, J.; MORRISON, T.; ANGELOS, M.; SAILOR, L.; SADAKA, R.; MILLER, B.; MILHEM, M.; MCCURDY, N.; KAIN, J.; NOHR, J.; JOHNSON, K.; MERRISS, A.; CHENG, E.; LUKE, D. G.; SCHARSCHMIDT, T. J.; CRIST, M. K.; DIMEO, A.; MARMON, L.; REIMER, N.; MONSON, D.; OSKOUEI, S.; LOMBA, C.; ROGERS, S.; GELLER, D.; HOANG, B.; TINGLING, J.; SOLORZANO, C.; AVEDIAN, R.; JORDAN, L.; CHINN, S.; HAMILTON, M.; PULOSKI, S.; MONUMENT, M.; CARCARY, K.; CAMERON, C.; ABOULAFIA, A.; LOO-MIS, M.; BOSLEY, J.; BONVEGNA, R.; KASSA, M.; DAMRON, T.; CRAIG, T.; REALE, M.; GOODMAN, H. J.; CULBERTSON, M. Deza; CARUSO, P.; GARLING, E.; SCHWAB, J.; FIORE, A.; PHUKAN, R.; PARK, C.; JOSHI, L.; ABOULAFIA, A.; WALLACE, M.; FLACK, J.; VAUGHAN, K.; AVERGAS, A.; BRADY, M.; BROWN, S.; SCHADIE, N.; BATTERSBY, R.; WEISS, K.; GOODMAN, M.; HEYL, A.; YESCHKE, C. A.; SUMIC, P.; DUDGEON, M.; PROSSER, R.; KORENOSKI, C.; DICAPRIO, M.; PALMER, B.; CIOPPA, E.; SCHAEFFER, T. M.; PAUL, P.; TORESON, J.; CUMMINGS, J.; SCHWARTZ, L.; ZAHNER, B.; MORRIS, C.; LALJANI, V.; MESKO, N.; JOYCE, M.; LIETMAN, S.; WUSTRACK, R.; O'DONNELL, R.; STEVENSON, C.; CARMODY, E.; TYLER, W.; MCINTYRE, A.; SPIGUEL, A.; SCARBOROUGH, M.; GIBBS, C. P.; STESHYN, J.; NUNN, B.; ROSENTHAL, H.; HAYNES, K.; LEDDY, L.; WALTON, Z.; DOUNG, Y-C.; HAYDEN, J.; VELEZ, R.; AGUIRRE, M.; PEREZ, M.; BARRERA, S.; LOPEZ, A. Garca; GRIMER, R.; DUNN, K.; VIRDEE, H.; RANKIN, K.; BECKINGSALE, T.; GERRAND, C.; CAMPBELL, I.; ALLEN, M.; KHAN, S. Alam; BAKSHI, S.; RASTOGI, S.; POUDEL, R.; KUMAR, V. Sampath; RAI, A.; BAPTISTA, A. M.; CAMARGO, O. P. de; MARAIS, L.; RODSETH, R.; FERREIRA, N.; RAJAH, C.; GUMEDE, S.; GORTZAK, Y.; STERNHEIM, A.; BICKELS, J.; KOLANDER, Y.; LEV, S.; HETTWER, W.; PETERSEN, M. M.; GRUM-SCHWENSEN, T.; JUTTE, P.; PLOEGMAKERS, J. J. W.; STEVENS, M.; MAHENDRA, A.; GUPTA, S.; BERGOVEC, M.; LEITHNER, A.; FUNOVICS, P.; DIJKSTRA, P. D. S.; SANDE, M. Van De; HOOGENSTRAATEN, A.; LEIJERZAPF, N.; STEADMAN, P.; STEADMAN, P.; BOFFANO, M.; PIANA, R.; MARONE, S.; ALBERTINI, U.; BOUX, E.; MAIELLO, A.; REPSA, L.; ZILE, S.; ASTON, W.; POLLOCK, R.; COOL, P.; GIBBONS, M.; WHIT-WELL, D.; COSKER, T.; HEMINGWAY, J.; PORTER, D.; PATTON, S.; NAVIA, J.; BETANCUR, A. F.; LAITENEN, M.; PAKARINEN, K.; NIEMINEN, J.; YLA-MONONEN, S.; RAUTIAINEN, S.; FIORENZA, F.
    Objective Clinical studies of patients with bone sarcomas have been challenged by insufficient numbers at individual centres to draw valid conclusions. Our objective was to assess the feasibility of conducting a definitive multi-centre randomised controlled trial (RCT) to determine whether a five-day regimen of post-operative antibiotics, in comparison to a 24-hour regimen, decreases surgical site infections in patients undergoing endoprosthetic reconstruction for lower extremity primary bone tumours. Methods We performed a pilot international multi-centre RCT. We used central randomisation to conceal treatment allocation and sham antibiotics to blind participants, surgeons, and data collectors. We determined feasibility by measuring patient enrolment, completeness of follow-up, and protocol deviations for the antibiotic regimens. Results We screened 96 patients and enrolled 60 participants (44 men and 16 women) across 21 sites from four countries over 24 months (mean 2.13 participants per site per year, standard deviation 2.14). One participant was lost to follow-up and one withdrew consent. Complete data were obtained for 98% of eligible patients at two weeks, 83% at six months, and 73% at one year (the remainder with partial data or pending queries). In total, 18 participants missed at least one dose of antibiotics or placebo post-operatively, but 93% of all postoperative doses were administered per protocol. Conclusions It is feasible to conduct a definitive multi-centre RCT of post-operative antibiotic regimens in patients with bone sarcomas, but further expansion of our collaborative network will be critical. We have demonstrated an ability to coordinate in multiple countries, enrol participants, maintain protocol adherence, and minimise losses to follow-up.
  • conferenceObject
    DURING TWO YEARS, WHAT IS THE DIFFERENCE BETWEEN AN EXCLUSIVE TWO-DAY EDUCATIONAL PROGRAM ON OA AND A PROGRAM THAT ADDS MULTIMODAL ATTENTION FOR 6 MOTHS IN THE TREATMENT OF OA?
    (2020) REZENDE, M. U.; OCAMPOS, G.; BRITO, N. R.; SABINO, F. F.; SILVA, C. C.; CERNIGOY, C. H.; STRUTZ, C.; SILVA, J. R.; SPADA, T. C.; SILVA, M. M.; CASTRO, D.; SANTOS, H. P.; SOUZA, R. A.; FRANCISCO, L. S.; CAMARGO, O. P.
  • article 5 Citação(ões) na Scopus
    Osteoid osteoma of the glenoid: Arthroscopic treatment
    (2015) MALAVOLTA, E. A.; ASSUNCAO, J. H.; REBOLLEDO, D. C. S.; GRACITELLI, M. E. C.; CORREIA, L. F. M.; FERREIRA NETO, A. A.; CAMARGO, O. P. de
    Osteoid osteoma is a benign tumor that is rarely found in the scapula. We report a clinical case involving a 36-year-old female patient who suffered from progressive pain in her right shoulder for 1 year. This patient was initially diagnosed with impingement syndrome and was treated unsuccessfully with medication and physical therapy for approximately 2 months. Based on imaging exams, a juxta-articular osteoid osteoma of the glenoid was identified. The patient underwent a shoulder arthroscopy that included tumor removal and treatment of the resulting chondral lesion. At 6-, 12- and 36-month assessments, the patient was asymptomatic, with a normal range of motion and experienced a pain intensity corresponding to 0 points on the Visual Analog Scale (VAS) and 35 points on the University of California, Los Angeles (UCLA) Scale. A postoperative MRI indicated the absence of any residual tumor tissue or inflammatory signs. We believe that the approach described in this paper allows juxta-articular osteoid osteomas to be accessed in a minimally invasive manner and permits not only adequate resection but also the treatment of chondral lesions that could remain after tumor resection.
  • article 2 Citação(ões) na Scopus
    HOW TO PERFORM A META-ANALYSIS: A PRACTICAL STEP-BY-STEP GUIDE USING R SOFTWARE AND RSTUDIO
    (2022) LIMA, D. I. E. G. O. A. R. I. E. L. DE; HELITO, C. A. M. I. L. O. P. A. R. T. E. Z. A. N. I.; LIMA, L. A. N. A. L. A. C. E. R. D. A. DE; CLAZZER, R. E. N. A. T. A.; GONCALVES, R. O. M. E. U. K. R. A. U. S. E.; CAMARGO, O. L. A. V. O. P. I. R. E. S. DE
    Meta-analysis is an adequate statistical technique to combine results from different studies, and its use has been growing in the medical field. Thus, not only knowing how to interpret meta-analysis , but also knowing how to perform one , is fundamental today. Therefore , the objective of this article is to present the basic concepts and serve as a guide for conducting a meta-analysis using R and RStudio software. For this, the reader has access to the basic commands in the R and RStudio software , necessary for conducting a meta-analysis. The advantage of R is that it is a free software. For a better understanding of the commands, two examples were presented in a practical way, in addition to revising some basic concepts of this statistical technique. It is assumed that the data necessary for the meta-analysis has already been collected , that is, the description of methodolo-gies for systematic review is not a discussed subject. Finally , it is worth remembering that there are many other techniques used in meta-analyses that were not addressed in this work. However , with the two examples used, the article already enables the reader to proceed with good and robust meta-analyses. Level of Evidence V, Expert Opinion.
  • article 5 Citação(ões) na Scopus
    VALUES OF ALKALINE PHOSPHATASE AND LACTATE DEHYDROGENASE IN EWING'S SARCOMA
    (2016) BAPTISTA, Andre Mathias; ZUMARRAGA, Juan Pablo; SANTOS, Renan Pires Negrao dos; HAUBERT, Guilherme de Oliveira; CAMARGO, Olavo Pires de
    Objective: To study the relationship between the serum levels of alkaline phosphatase (AP) and lactate dehydrogenase (LDH), and the percentage of tumor necrosis (TN) in patients with Ewing's Sarcoma (ES). Methods: This is a case series with retrospective evaluation of patients with diagnosis of ES divided into 2 groups: Group 1, patients whose serum levels of alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) were obtained in the staging phase before preoperative chemotherapy (CT), and Group 2, patients whose values were measured after completion of the preoperative CT. The percentage of tumor necrosis (TN) of surgical specimens extracted in surgery was also evaluated. Results: Eighty four medical records from 1995 to 2015 were included. Both AP as LDH decreased in the patients studied, the pre CT value being higher than the post CT value. The average decrease of LHD was 272.95 U/L and AP was 10.17 U/L. The average tumor necrosis was 65.12 %. There was no statistical correlation between serums levels and the tumor necrosis percentage. Conclusion: The serum levels values of AP and LDH are not predictors for chemotherapy-induced necrosis in patients with ES.
  • bookPart
    Abordagem da endoprótese oncológica infectada
    (2013) CAMARGO, Olavo Pires de